missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BMPER Polyclonal Antibody

Description
In Western blots, approximately 50% cross-reactivity with recombinant human CV-2 is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis.
Specifications
Specifications
| Antigen | BMPER |
| Applications | Immunohistochemistry (Frozen), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | Bmper |
| Gene Accession No. | Q8CJ69 |
| Gene Alias | BMP-Binding Endothelial Regulator Protein; CRIM3 |
| Gene Symbols | Bmper |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?